Advanced Human Imaging Limited Sponsored ADR AHI
1.50
0.00
0.00%
as of 14 Aug
- Market cap
- $13.2M
- P/E
- 0.0×
Follow AHI
Growth Flags
show if company had growth for consecutive years
| Older periods | Jun '22 | Dec '22 | Jun '23 | Dec '23 | |
|---|---|---|---|---|---|
P/E ratio |
+6 more quarters Free account |
0.00 | 0.00 | 0.00 | — |
P/S ratio |
27.30 | 33.06 | 60.75 | — | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | — | |
P/Operating CF |
(2.28) | (4.96) | (7.08) | — | |
P/B ratio |
2.62 | 3.43 | 25.71 | — | |
Price to Tangible BV |
2.96 | 13.13 | 0.00 | — | |
EV/Sales |
21.43 | 35.26 | 60.32 | — | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | — | |
EV/Operating CF |
(0.87) | (0.91) | (1.99) | — | |
EV/FCF |
(0.86) | (0.91) | (1.97) | — | |
Quick Ratio |
2.96 | 0.56 | 0.40 | 0.10 | |
Current Ratio |
3.40 | 0.90 | 0.54 | 0.20 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
10.41% | 17.90% | 19.51% | 50.43% | |
Debt/Equity |
0.13 | 0.32 | 0.86 | (1.14) | |
Asset Turnover |
0.11 | 0.07 | 0.10 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.24) | 0.00 | (0.18) | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | — | |
Selling, General and Administrative Expense of Revenue |
14,836.51% | 1,497.99% | 2,476.05% | — | |
Intangible Assets out of Total Assets |
0.09 | 0.41 | 0.48 | 0.59 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | |
Graham Net Nets |
0.22 | (0.07) | (0.07) | — | |
Graham Number |
0.00 | 0.00 | 0.00 | — | |
Earnings Yield |
(8.54%) | (10.01%) | (3.84%) | — | |
Free Cash Flow Yield |
(91.39%) | (117.67%) | (50.37%) | — | |
Revenue per Share |
0.01 | 0.03 | 0.02 | — | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(7.22) | (2.88) | (5.01) | (3.13) | |
Working Capital |
3.56 | (0.27) | (1.87) | (4.31) | |
Capital Expenditures |
(0.06) | 0.00 | (0.05) | 0.00 | |
Net Current Asset Value |
3.52 | (1.02) | (2.44) | (5.61) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(14,693.71%) | (1,091.45%) | (3,057.20%) | — | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | — | |
| Other line items | |||||
Average Receivables |
0.17 | 0.58 | 0.23 | 0.16 | |
Average Payables |
0.57 | 0.67 | 1.44 | 1.94 | |
Average Assets |
5.35 | 6.47 | 5.71 | 8.38 | |
Average Common Equity |
3.33 | 3.62 | 1.67 | 3.72 |
Columns are period end dates